| Product Name | MF | CAS | Details |
|---|
| GSK 591 dihydrochloride | C22H29ClN4O2 | 2320953-89-5 | Details |
| (4-(4-(tert-butyl)phenyl)(2,5-thiazolyl))(4-(trifluoromethoxy)phenyl)amine, chloride | C20H20ClF3N2OS | 1274904-21-0 | Details |
| CALR3 protein (His tag) | Details |
| 4-(Bromomethyl)-1-phenyl-1H-1,2,3-triazole | C9H8BrN3 | 58432-26-1 | Details |
| 4-Amino-benzoic acid 2-oxo-2-phenyl-ethyl ester | C15H13NO3 | 107692-58-0 | Details |
| 3-Phenylpyridine-2-carboxylic acid | C12H9NO2 | 103863-15-6 | Details |
| HXB2 gag NO-8 | C89H142N26O22 | Details |
| ST8SIA4 antibody | Details |
| Lipase 003 | C11H9N3NaO2+ | 9001-62-1 | Details |
| 2-Chloro-N-(4-chloro-2-methoxy-5-methylphenyl)propanamide | C11H13Cl2NO2 | 923681-65-6 | Details |
| L-Threonic acid | C4H8O5 | 7306-96-9 | Details |
| 2-Chloro-4-ethoxybenzaldehyde | C9H9ClO2 | 245368-31-4 | Details |
| 3,5,5-Trimethyl-2-pyrrolidinone | C7H13NO | 14482-00-9 | Details |
| {Bicyclo[2.2.1]heptan-2-yl}hydrazine dihydrochloride | C7H16Cl2N2 | 1432680-22-2 | Details |
| o-(Oxolan-3-ylmethyl)hydroxylamine hydrochloride | C5H12ClNO2 | 854382-86-8 | Details |
| 4-(1H-1,2,4-Triazol-1-yl)-3-(trifluoromethyl)aniline | C9H7F3N4 | 351325-27-4 | Details |
| 1-Methyl-5-(oxolan-2-yl)-1H-pyrazole-3-carboxylic acid | C9H12N2O3 | 1888891-92-6 | Details |
| 1-Amino-N-(propan-2-yl)cyclopropane-1-carboxamide hydrochloride | C7H15ClN2O | 2287279-18-7 | Details |
| 4,5-Difluoro-2-methylbenzoic acid | C8H6F2O2 | 183237-86-7 | Details |
| Recombinant Mouse TNF-alpha | Details |
| FKBPL Blocking Peptide | Details |
| ESM1 protein (His tag) | Details |
| 1-(4-Chlorophenyl)-5-phenylpentan-2-one | C17H17ClO | 1179919-66-4 | Details |
| L-(+)-Threo-2-(N,N-dimethylamino)-1-(4-aminophenyl)-1,3-propanediol | C11H18N2O2 | 129170-43-0 | Details |
| Succinylsulfathiazole | C13H13N3O5S2 | 116-43-8 | Details |
| 3-Iodo-pyrazolo[1,5-a]pyridine | C7H5IN2 | 19363-99-6 | Details |
| Methyl 1H-indazole-3-carboxylate | C9H8N2O2 | 43120-28-1 | Details |
| (2,6-Dichloro-3-pyridinyl)methanol | C6H5Cl2NO | 55304-90-0 | Details |
| 2-Bromostyrene | C8H7Br | 2039-88-5 | Details |
| 3-Methyl-5-(methylamino)-1,2-thiazole-4-carbonitrile | C6H7N3S | 88394-37-0 | Details |
| 3-n-Butylphthalide | C12H14O2 | 6066-49-5 | Details |
| 4-Hydroxyphenethyl alcohol | C8H10O2 | 501-94-0 | Details |
| N-(((6-methoxy(3-pyridyl))amino)thioxomethyl)benzamide | C14H13N3O2S | 96938-52-2 | Details |
| 5-(Chloromethyl)-1-(oxan-4-yl)-1H-1,2,3,4-tetrazole | C7H11ClN4O | 1340126-75-1 | Details |
| DAND5 antibody | Details |
| (3-Phenylpiperidin-3-yl)methanol hydrochloride | C12H18ClNO | 2060037-56-9 | Details |
| 1-(3,4-Dihydro-2H-1,5-benzodioxepine-7-sulfonyl)piperazine hydrochloride | C13H19ClN2O4S | 1803587-20-3 | Details |
| 4-Chloro-2-phenylquinazoline | C14H9ClN2 | 6484-25-9 | Details |
| C-(2-Methyl-2H-pyrazol-3-yl)-methylaminedihydrochloride | C5H11Cl2N3 | 1185299-87-9 | Details |
| rac-(1R,2R)-1-(Aminomethyl)-2-methanesulfonylcyclopropane-1-carboxylic acid hydrochloride | 2138180-95-5 | Details |
| 2-(3-Fluorophenyl)-2-(methylamino)ethan-1-ol | C9H12FNO | 1183031-78-8 | Details |
| Methyl 2-amino-5-(trifluoromethoxy)benzoate | C9H8F3NO3 | 312295-61-7 | Details |
| 1-Cyclohexyl-5-oxopyrrolidine-3-carboxylic acid | C11H17NO3 | 6304-56-9 | Details |
| 2-tert-Butyl-4-fluoro-5-methylphenol | C11H15FO | 220901-47-3 | Details |
| 3-(Piperidine-1-sulfonyl)thiophene-2-carboxylic acid | C10H13NO4S2 | 923697-76-1 | Details |
| 1-(2-bromophenyl)cyclobutane-1-carboxylic acid | C11H11BrO2 | 151157-44-7 | Details |
| chroman-7-ylboronic acid pinacol ester | C15H21BO3 | 1807699-68-8 | Details |
| 2-[(tert-butoxy)carbonyl]-5-thia-2-azaspiro[3.4]octane-8-carboxylic acid | C12H19NO4S | 1373029-39-0 | Details |
| N-{[(4-Chlorophenyl)carbamothioyl]amino}-2-phenylacetamide | C15H14ClN3OS | 72293-65-3 | Details |
| Hypoglycine | C7H11NO2 | 156-56-9 | Details |
| Annexin A2 Blocking Peptide | Details |
| 2-Aminoethyl Sulfate | C2H7NO4S | 926-39-6 | Details |
| 3-Bromo-2-ethyl-1-benzofuran | C10H9BrO | 325465-53-0 | Details |
| 5-Chloro-3-(3-methoxyphenyl)-1,2,4-oxadiazole | C9H7ClN2O2 | 1179242-59-1 | Details |
| (2R,2'R,3S,3'S,4R,4'R,5S,5'S)-6,6'-(1,4-Phenylenebis(ethyne-2,1-diyl))bis(2-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | GaI3 | 13450-91-4 | Details |
| 6-Ethyl-4-methyl-1,2-dihydropyrimidin-2-one | C7H10N2O | 751425-72-6 | Details |
| AD-mix-beta | C48H54N6O4 | 148618-32-0 | Details |
| 1,5-Dimethyl-1H-imidazole-2-carbaldehyde | C6H8N2O | 955028-18-9 | Details |
| 2-Phenoxyethyl Isobutyrate | C12H16O3 | 103-60-6 | Details |
| 5-Chloro-2-methylbenzoic acid | C8H7ClO2 | 7499-06-1 | Details |
| Ethyl 3-hydroxybenzoate | C9H10O3 | 7781-98-8 | Details |
| tert-Butyl N-{[1-(aminomethyl)spiro[2.3]hexan-1-yl]methyl}carbamate | C13H24N2O2 | 2228153-22-6 | Details |
| (5-Methyl-1H-benzoimidazol-2-ylsulfanyl)-acetic acid | C10H10N2O2S | 27231-37-4 | Details |
| 2-?Amino-?N-?(dimethyloxido-?λ4-?sulfanylidene)?-?acetamide hydrochloride | C4H11ClN2O2S | 1955520-93-0 | Details |
| Methyl 5-bromo-2-chloro-4-methylbenzoate | C9H8BrClO2 | 1695248-17-9 | Details |
| H-Pro-His-Tyr-OH | C20H25N5O5 | 81075-04-9 | Details |
| PPAR Delta Blocking Peptide (Mouse) | Details |
| (4R)-2-Phenyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid | C10H9NO2S | 62096-93-9 | Details |
| Duloxetine-4-hydroxy-D-glucuronide | C24H27NO8S | 741693-83-4 | Details |
| (2-Chloro-5-methylphenyl)acetic acid | C9H9ClO2 | 81682-39-5 | Details |
| (1-Methyl-1,2,3,4-tetrahydroquinolin-4-yl)methanamine | C11H16N2 | 646997-14-0 | Details |
| Globotriose-GEL | Details |
| Ethyl 2-azabicyclo[2.1.1]hexane-1-carboxylate hydrochloride | 1989671-42-2 | Details |
| (3-(trifluoromethyl)phenyl)-N-(4-(2,6,6-trimethyl-4-oxo(5,6,7-trihydroindolyl))phenyl)formamide | C25H23F3N2O2 | 1024231-00-2 | Details |
| 9-Bromo-5-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepine-7-carboxylic acid | C10H8BrNO4 | 2138166-16-0 | Details |
| 5-Nitroquinoline-8-carbaldehyde | C10H6N2O3 | 860758-26-5 | Details |
| PCDHB5 antibody | Details |
| Methyl 4-(aminomethyl)-5-methylfuran-2-carboxylate hydrochloride | 35842-91-2 | Details |
| 6-Chloroquinoline-7-carboxylic acid hydrochloride | C10H7Cl2NO2 | 2287323-23-1 | Details |
| 4-Methyl-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-oxane]-1-amine hydrochloride | 2241127-88-6 | Details |
| 1-(3-Cyanobenzyl)imidazole | C11H9N3 | 143426-59-9 | Details |
| LCMV antibody | Details |
| Methyl 4-aminopiperidine-1-carboxylate hydrochloride | C7H15ClN2O2 | 1187160-88-8 | Details |
| 3-Amino-2,2-dimethyl-3-(1-methyl-1H-imidazol-2-yl)propan-1-ol | C9H17N3O | 1862648-08-5 | Details |
| Thiodiglucoside | C12H22O10S | 108392-13-8 | Details |
| 3-[(2-Bromophenyl)methyl]azetidine, trifluoroacetic acid | C12H13BrF3NO2 | 2095408-96-9 | Details |
| [4-(1,1-Difluoroethyl)phenyl]methanamine | C9H11F2N | 790601-53-5 | Details |
| N6-Benzoyl-9-(3'-O-Deoxy-3'-fluoro-b-D-xylofuranosyl)adenine | Details |
| Methyl-2-benzyl-5-methyl-octahydro-1H-pyrrolo[3,4-c]pyridine-7a-carboxylate | C17H24N2O2 | 1820570-25-9 | Details |
| 2-Oxo-2,5,7,8-tetrahydro-1H-pyrano[4,3-b]pyridine-3-carboxylic acid | C9H9NO4 | 1248899-71-9 | Details |
| Rabbit anti Dog IgG (biotin) | Details |
| Thalicminine | C20H15NO6 | 16408-77-8 | Details |
| 1,3,5-Tribromo-1,2,4-triazine | C2Br3N3 | 15814-02-5 | Details |
| AGXT2 Blocking Peptide | Details |
| CEBPB antibody | Details |
| 4-[(Naphthalen-2-yloxy)methyl]benzohydrazide | C18H16N2O2 | 377769-56-7 | Details |
| MOR1 antibody | Details |
| Fmoc-Lys(Boc)-Wang resin (100-200 mesh) | Details |
| 2,2-Dimethyl-1-indanone | C11H12O | 10489-28-8 | Details |
| 4-Methanesulfonyl-3-(morpholin-4-yl)-1H-pyrazol-5-amine | C8H14N4O3S | 1415138-74-7 | Details |
| Product Total： Product Page： | ||||
| 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 | ||||